Audiogenic reflex seizures in cats by Lowrie, M et al.
  1 
 
 
 
 
 
ARTICLE 
 
Audiogenic reflex seizures in cats  
 
Mark Lowrie 
a, Claire Bessant 
b, Robert J Harvey
 c, Andrew Sparkes 
b, Laurent Garosi 
a 
 
a Davies Veterinary Specialists, Manor Farm Business Park, Higham Gobion, Hitchin,  
SG5 3HR, England; 
 
b International Cat Care, Taeselbury, High Street, Tisbury, Wiltshire, SP3 6LD, England; 
 
c Department of Pharmacology, UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 
1AX, England 
 
Correspondence author: Mark Lowrie, Davies Veterinary Specialists, Manor Farm Business Park, 
Higham Gobion, Hitchin, SG5 3HR, England. 
Tel: +44 1582 883 950, fax: +44 1582 883 946 
E-mail address: mll@vetspecialists.co.uk 
 
Running Title: Feline Audiogenic Reflex Seizures 
Keywords: Seizure, cat, reflex, audiogenic, myoclonus 
Work  was  done  at:  Davies  Veterinary  Specialists,  Manor  Farm  Business  Park,  Higham  Gobion, 
Hitchin, SG5 3HR, England and Animal Health Trust, Centre for Small Animal Studies, Newmarket, 
Suffolk, CB8 7UU, England 
Conflict  of  Interests  Statement:  None  of  the  authors  of  this  paper  has  a  financial  or  personal 
relationship with other people or organizations that could inappropriately influence or bias the content 
of this paper. 
 
Lowrie, M; Bessant, C; Harvey, RJ; Sparkes, A; Garosi, L; (2015) Audiogenic reflex seizures in 
cats. Journal of Feline Medicine and Surgery 10.1177/1098612X15582080. (In press). 
Downloaded from UCL Discovery: http://discovery.ucl.ac.uk/1468712/   2 
Acknowledgements: The authors thank all owners and primary veterinarians for participating in this 
study. Special thanks are given to Rory Burke, Jasper Copping, Melva Eccles, Dr Malcolm Gamble 
and Dr Kim Kendall for their work with this study. 
 
Funding statement: This research received no grant from any of the public, commercial or not-for-
profit funding agencies. 
Word Count: 5071   3 
Abstract 
This study aims at characterizing feline audiogenic reflex seizures (FARS). An online questionnaire was 
developed  to  capture  information  from  owners  with  cats  suffering  FARS.  This  was  collated  with  the 
medical records from the primary veterinarian. 
 
Ninety-six cats were included. Myoclonic seizures were one of the cardinal signs of this syndrome 
(90/96), frequently occurring prior to generalized tonic-clonic seizures (GTCS) in this population. Other 
features  include  a  late-onset  (median  15  years)  and  absence  seizures  (6/96),  with  most  seizures 
triggered  by  high frequency  sounds  amid  occasional  spontaneous  seizures  (up  to  20%).  Half  the 
population (48/96) had hearing impairment or were deaf. One third of cats (35/96) had concurrent 
diseases,  most  likely  reflecting  the  age  distribution.  Birmans  were  strongly  represented  (30/96). 
Levetiracetam  gave  good  seizure  control.  The course  of  the  epilepsy  was  non-progressive  in  the 
majority  (68/96)  with  an  improvement  over  time  in  some  (23/96).  Only  33/96  and  11/90  owners 
respectively felt the GTCS and myoclonic seizures affected their cat’s quality of life (QoL). Despite 
this,  many owners (50/96) reported a slow decline in their cat’s health becoming less responsive 
(43/50),  not  jumping  (41/50),  uncoordinated  or  weak  in  the  pelvic  limbs  (24/50),  and  exhibiting 
dramatic weight loss (39/50). These signs were exclusively reported in cats experiencing seizures for 
>2 years with 42/50 owners stating these signs affected their cat’s QoL. 
 
In gathering data on audiogenic seizures in cats, we have identified a new epilepsy syndrome named 
FARS  with  a  geriatric-onset.  Further  studies  are  warranted  to  investigate  potential  genetic 
predispositions to this condition. 
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Introduction 
A  reflex  seizure  is  defined  as  a  seizure  that  is  objectively  and  consistently  precipitated  by 
environmental  or  internal  stimuli.  It  is  differentiated  from  spontaneous  epileptic  seizures  in  which 
precipitating  factors  cannot  be  identified
1.  Reflex  epilepsy  syndrome  is  therefore  one  in  which  all 
seizures are precipitated by sensory stimuli. However, some authors suggest that this definition is too 
restrictive and only the majority of seizures need to be precipitated by sensory stimuli to constitute a 
reflex  epilepsy  syndrome
2.  Audiogenic  reflex  seizures  describe  those  predominantly  induced  by 
sounds. 
 
Reflex seizures may occur in human patients with idiopathic, symptomatic or probably symptomatic 
epilepsies
2. Reflex seizures are reported to be either generalized; such as absences (non-convulsive), 
myoclonic jerks, or tonic-clonic seizures; or focal
1. A specific stimulus may result in isolated absences, 
myoclonic jerks, or generalized tonic-clonic seizures (GTCS) or may cause combinations of all three. 
Patients may exhibit reflex as well as spontaneous seizures
2. Myoclonic jerks are by far the most 
common type of reflex seizures and may manifest initially in the limbs and body, or focally involving 
just  the  face  or  a  single  limb.  Reflex  absence  seizures  are  common  in  people,  with  reflex  focal 
seizures being much less common. 
 
In summary, reflex seizures can occur with any epilepsy type and the stimulus may be very specific. 
Numerous  epileptic  seizure  syndromes  involving  reflex  seizures  are  described  although  a  robust 
classification scheme for reflex epilepsies remains elusive. 
 
The authors have become aware increasingly of audiogenic reflex seizures in cats. A questionnaire-
based method was used to gather data to better  define and characterize the phenotype of feline 
audiogenic reflex seizures (FARS). The purpose of this paper was to provide a description of this 
syndrome.  
 
Materials and Methods 
 
Case Recruitment 
Cases were recruited via the veterinary media (The Veterinary Times and Veterinary Record), internet 
(solicitation on cat forums, Facebook and the International Cat Care website) and International press 
(radio  and  newspaper  driven)  asking  primary  veterinarians  and  owners  to  contact  us  regarding 
suspected  cases  of  audiogenic  seizures  in  cats.  Pedigrees,  medical  history  information,  litter 
information, and cheek swab samples for DNA isolation were collected where possible. A detailed 
invitation-only  questionnaire  was  prepared  and  was  preceded  by  owner  interview  via  phone   5 
conversation or email in which an open description of the seizure types was given by the owner. On 
obtaining a description considered compatible with a seizure (as determined by one of the authors, 
ML)  the  questionnaire  invitation  was  given.  Where  available,  video  recordings  of  episodes  were 
reviewed  to  characterize  that  the  episodes  truly  represented  an  epileptic  seizure.  In  the  cases 
recruited via primary veterinarians a full history was also requested and reviewed. If the owner had 
contacted us directly and was included in the study consent was obtained to request and review the 
history from their primary  veterinarian. This history supplemented the information gained from the 
questionnaire. Data were acquired from September 2013 to March 2014. 
 
Questionnaire Design 
The questions  used  in  this  questionnaire  are  detailed  in  the  supplementary  text  file  (online). The 
questionnaire  was  divided  into  four  sections  with  each  section  having  its  own  purpose.  The 
questionnaire  contained  numerous  open-ended  questions,  to  which  the  answer  was  recorded 
verbatim, followed by specific leading questions. The majority of questions were closed questions with 
multiple choice answers. Questions were also included to help recognize those participants that did 
not fulfill the inclusion criteria in order to ensure they were correctly excluded.  Questions directed 
towards  the  types  and  characteristics  of  the  episodes  also  included  an  opportunity  to  provide  a 
description  verbatim  of  the  episodes.  Where  more  than  one  type  of  episode  was  observed, 
participants were asked to characterize each individually. The questions were therefore divided across 
the  sections  into  those that  screened  cats for audiogenic  reflex  seizures  and  those that  provided 
detailed phenotypic information in terms of the signalment of animals, possible precipitating factors, 
general health, therapeutic trials where relevant and the characteristics of the episodes. Questions 
were randomized within each section to prevent owners from drawing conclusions about the expected 
answer.  The  project  questionnaire  was  presented  online  utilizing  the  online  survey  software  tool 
SurveyMonkey (http://www.surveymonkey.com). 
 
Inclusion criteria 
Inclusion criteria were in place to exclude other disease processes that may be misinterpreted as an 
epileptic seizure or paroxysmal behavior. It was important that all cats had to have suffered three or 
more GTCS that had been precipitated by the same sound stimulus. A GTCS was considered only if 
strict criteria were met, notably the presence of tonic-clonic contractions of all limbs, and the presence 
of an altered consciousness with autonomic signs (specifically urination and/or salivation). A GTCS 
was  also  excluded  if  the  duration  was  reported  to  be  greater  than  5  minutes.  If  other    types  of 
episodes were present in addition to a confirmed GTCS, the features of these episodes were recorded 
individually  in  the  questionnaire.  A  myoclonic  seizure  or  jerk  was  considered  when  there  was  a 
sudden, brief involuntary contraction of a muscle or muscle group. Absence seizures were considered   6 
as the occurrence of an abrupt, transient apparent loss of consciousness with no motor activity. All 
cats had to have at least a one year history of seizures. 
 
Results 
There were 128 respondents to the questionnaire. Thirty-two cats were excluded because they did not 
meet the inclusion criteria. This included 16 cats that had suffered less than three GTCS, 10 cats that 
had a history of GTCS seizures for less than one year, four cats that had no reported autonomic signs 
during the episodes, and two cats that had seizures reported to be longer than 5 minutes in duration. 
 
Signalment 
Details on 96 cats were therefore collected comprising 45 domestic short-haired (DSH), 30 Birman 
cats, 6 Burmese cats, 5 domestic long-haired (DLH), 4 Bengal cats, 2 Maine coons, and one of each 
of the following cats: British Shorthair, European shorthair, Norwegian Forest cat and Birman cross. Of 
the Birman cats, 12 (12/30; 40%) were blue point and 18 (18/30; 60%) were seal point. 
 
The mean age of the cats at seizure onset was 15 years (median 15 years; range, 10-19 years). Forty-
seven cats were female (64%; 30/47 neutered) and 49 were male (71%; 35/49 neutered). 
 
Sound stimulus 
All  seizures,  as  per  the  inclusion  criteria,  occurred  following  a  noise  stimulus  but  in  some  cats 
spontaneous myoclonic jerks (18/90; 20%) and GTCS (8/96; 8%) were observed on rare occasions 
without an obvious noise stimulus. All sounds triggering these seizures were high-pitched. The sounds 
were capable of triggering different seizure types with no distinct sound predicting or producing a 
distinct seizure pattern. In some cases, a repeated sound initiated a myoclonic seizure that, when 
prolonged, could progress to a GTCS. This phenomenon of audiogenic kindling was reported in 86 
cats. These sounds had not always caused cats to seizure and could occur without causing seizures 
on  occasion  in  32/96  cats  (33%).  Avoiding  these  noises  eliminated  seizures  in  72/96  cats  (75%) 
although many owners remarked that the nature of the sounds made it very difficult to eradicate the 
seizures  completely.  All  owners  felt  they  could  reliably  induce  a  seizure  by  making  one  of  the 
described trigger noises. The loudness of the sound (amplitude) also seemed to increase the severity 
of seizures regardless of the type of seizure. This was reported by 23% (22/96) owners. 
 
Sound stimuli identified to evoke seizures in cats included: the crinkling of tin foil (n=82); a metal 
spoon dropping into a ceramic feeding bowl (n=79); the chinking or tapping of glass (n=72); paper or 
plastic bags crinkling (n=71); computer keyboard tapping or mouse clicking (n=61); the clinking of 
coins or keys (n=59); the hammering of a nail (n=38); the clicking of an owner’s tongue (n=24); the   7 
sound of breaking the tin foil from treatment or tablet packaging (n=12); texting (n=8); a digital alarm 
(n=6); the sound of velcro (n=6); the clicking of a piezo lighter for a gas stove or the sound made by 
igniting the gas hob (n=4); a cellphone ring (n=4); running water (n=2); the sound created by a dog 
scratching her neck and jangling her collar (n=2); a computer printer (n=2); firewood spitting (n=1); 
wooden building blocks being knocked together (n=1); walking on a wooden floor with bare feet or 
squeaky  shoes  (n=1);  and  the  short  sharp  scream  of  a  young  child  (n=1).  There  were  no  other 
reported precipitating factors that could induce a seizure or make one more likely to occur. 
 
Clinical Features 
Apart from GTCS, cats developed other seizure types (see figure 1); myoclonic jerks (90/96; 94%) and 
clinical absences or presumed absence seizures (6/96; 6%). The majority of cats (84/96; 88%), had 
myoclonic jerks and GTCS; with six (6/96; 6%) cats having the triad of absence seizures, myoclonic 
jerks and GTCS. Six cats (6/96; 6%) had only GTCS. Absence seizures antedated myoclonic jerks in 
all the six cats (6/96) with this seizure type. The first seizure observed by the owner was a GTCS in 
17% (16/96) of cats, a myoclonic seizure in 70% (67/96) cats and an absence seizure in 6% (6/96) 
cats. Seven (7/96; 7%) owners were uncertain which seizure type was observed first. All cats were 
reported to be normal in-between the seizures. 
 
1)  GTCS 
GTCS were present in all cats as per the inclusion criteria. Therefore all had an altered consciousness 
with episodes lasting less than 5 minutes. Urination was recorded in 74/96 (77%) and salivation in 
83/96 (86%) cats. Videos were provided in three cases that confirmed their nature as GTCS. The 
seizures never occurred more frequently than one per 24-hours period (i.e. clusters). GTCS were 
often (86/96; 90%) preceded by generalized myoclonic jerks, most commonly of the head (82/96; 
85%). GTCS indicated their coming just minutes in advance with a series of rapid myoclonic jerks of 
increasing intensity. GTCS most commonly occurred at a frequency of one every 3-6 months although 
overall this was highly variable with periods as long as 18 months between seizures. 
 
Fifty-eight cats (82/96; 85%) were ataxic following a GTCS with hunger (69/96; 72%), restlessness 
(42/96; 44%), seeking to be near their owners (21/96; 22%), and thirst (6/96; 6%) also being reported. 
These post-ictal signs abated within 24 hours in all cats. However, many cats improved within hours 
(31/96; 32%) or (30/96; 31%) minutes of a GTCS. 
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2)  Myoclonic Seizures 
Myoclonic jerks or seizures without apparent loss of consciousness were frequently reported (90/96; 
94%). The jerks were described as brief (always less than 30 seconds), commonly bilateral, rhythmic 
contractions  that  mainly  started  in  the  head  and  neck  (79/90;  88%)  or  occasionally  in  the 
back/abdomen (11/90; 12%). However, all owners report that the jerking could spread to involve the 
shoulders and forelimbs (86/90; 96%), and/or hips and pelvic limbs (83/90; 92%). Some jerks occur 
unilaterally (12/90; 13%) but none were reported to involve only a single part of the body. Videos were 
provided in 23/96 cats that confirmed the nature of these myoclonic seizures (see supplementary 
video  file,  online).  All  owners  reported  that  consciousness  was  unaffected  during  these  jerks. 
However,  video  footage  suggested  there  was  some  degree  of  impairment,  albeit  brief.  This 
discrepancy  is  understandable  given  the  short  duration  of  the  seizures  and  so  impairment  of 
consciousness should be considered likely in these cats. 
 
Myoclonic  jerks  were  more  likely  to  occur  in  clusters  (88/90;  98%)  than  as  single  episodes.  The 
frequency and intensity of myoclonic jerks varied from up to 20 in a day to one every 3-6 months. 
Owners reported that more violent jerks could result in cats falling to the floor. Rapid successive jerks 
would frequently evolve into a GTCS (86/90; 96%). 
 
The majority of cats were normal immediately following a myoclonic episode (88/90; 98%) although 
two cats were reported to be more sleepy than normal within the first few hours only. No other post-
ictal signs were noted for this type of seizure. 
 
The 16 cats that were excluded due to suffering less than three GTCS included 14/16 that reported 
regular myoclonic jerks in response to specific sounds. Some of these cats (12/16) had no reported 
episodes of GTCS. However, these cats have not been included in the study population. 
 
3)  Absence Seizures 
Periods of absence were reported but rarely within this population. Absences were considered when 
the owners reported periods of staring with no motor activity (6/96; 6%). These episodes would almost 
always precede myoclonic jerks. Episodes lasted between 30 seconds to one minute in all six cats. A 
few seconds after each episode, the cats were reported to be quieter than usual by the owners and 
slower to respond. Post-ictal signs were varied with all owners describing sleepiness and a perceived 
feeling of their cat experiencing disorientation. These signs could last up to a few hours (4/6; 67%) or 
even up to one day (2/6; 33%). 
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Investigations 
Diagnostic  investigations  were  pursued  in  85/96  cats  (89%).  Hematology  and  biochemistry  were 
performed in 82/85 cats. Urinalysis (including specific gravity and dipstick) was performed in 72/85 
cats. Blood pressure recording was performed in 52/85 cats. Magnetic resonance imaging of the brain 
had been performed in 32/85 cats, and computed tomography in 3/85 cats. The results of cross-
sectional imaging in these 35 cats were normal. Cerebrospinal fluid was performed in 18 cats and the 
results were unremarkable. Toxoplasma and neospora serology was performed in 48/96 and 12/96 
cats respectively and revealed no evidence of active infection. FeLV and FIV testing was performed in 
12/85 cats and was negative in all.  
 
Concurrent diseases 
Concurrent diseases reported by the owners and corroborated by primary veterinary surgeon notes 
were diagnosed in 35 cats (35/85; 40%). This included chronic renal disease (21/85), hyperthyroidism 
(6/85), hypertrophic cardiomyopathy (3/85), hypertension (3/85), and diabetes mellitus (2/85). The cats 
with concurrent diseases did not have a progressive seizure course with seizures remaining static in 
21/35 and improving in 14/35 cats. 
 
The mean weight of cats was 4.2 kg (median 4kg; range, 2-10kg). Sixty percent of cats (58/96) were 
described as ‘eating all meals’, with 25% (24/96) described as picky eaters and 6% (6/96) having a 
poor appetite. Eight percent of cats (8/96) were described as hungry all the time. Episodes of diarrhea 
or  vomiting  were  described  as  frequent  (6%;  6/96),  occasional  (42%;  40/96),  or  infrequent  (20%; 
19/96) with 31/96 cats having no reported episodes (32%). Twenty-seven percent of cats (26/96) were 
reported to have itchy skin, excessive licking or feet/ear problems although no known allergies were 
reported by the owners. No owners reported coughing, collapsing or breathing difficulties. Fifty percent 
of cats (48/96) were described as having hearing impairment including five cats where the owners 
considered they were completely deaf. Sixteen of these cats (16/48) had cross-sectional imaging of 
the head (4/16 had CT and 12/16 had MRI) revealing no obvious cause for this apparent hearing 
impairment. Further, 21% (20/96) of cats were described to have visual impairment, including three 
cats where the owners thought they were completely blind. 
 
Treatment 
Treatment was pursued in 44/96 cats. 15 cats had received phenobarbital and 29 cats had received 
levetiracetam.  Among  the  15  cats  taking  phenobarbital,  4/15  (27%)  experienced  adequate  GTCS 
control although only one owner felt it reduced the frequency of the myoclonic seizures (7%). The 
remainder were reported by the owners to have no change in seizure frequency. All cats had received 
this drug for a minimum of six weeks before discontinuing the medication. Serum concentrations were   10 
only available in 3/15 cats and were within published reference ranges but dosages were available in 
all 15 cats and were considered acceptable. Levetiracetam gave good control of both the GTCS and 
myoclonic  seizures  in  20/29  (69%)  and  27/29  (93%)  cats  respectively.  The  remaining  cats  were 
reported by the owners to have no change in seizure frequency. Dosages were available in 27/29 cats 
and were considered adequate and all cats had received the medication for at least two months. 
Additionally,  those  cats receiving  no  medication for  seizure  control  did  not  appear  to  progress  or 
deteriorate during the course of their seizures. 
 
Outcome 
Twenty-two cats are dead at the time of writing and all were euthanized. All 22 cats had suffered 
seizures up until the point of euthanasia therefore the average duration of seizures in these cats was 
24  months  (range,  13  months  to  38  months);  median  duration  was  23  months.  The  reason  for 
euthanasia  was  seizure-related  in  just  one  cat.  The  remaining  21  cats  were  euthanized  due  to 
concurrent diseases or a decline in condition.  
 
The onset of epilepsy was highly variable with single seizures or clusters being observed. The course 
of the epilepsy was non-progressive in the majority of cats (68/96; 71%) with some owners reporting 
an improvement with time (23/96; 25%). 33/96 (33%) owners stated that the GTCS affected their cat’s 
quality of life but a much lower proportion (12%; 11/90) felt the myoclonic seizures affected their cat’s 
quality of life. 
 
Although the seizures were not a concern to the majority, many owners (50/96; 52%) reported a slow 
decline in their cat’s health in that they became in coordinated or weak in the pelvic limbs (24/50), less 
responsive  (43/50),  stopped  jumping  (41/50),  experienced  dramatic  (>1kg)  weight  loss  (39/50), 
toileted  inappropriately  in  the  house (12/50),  and  got stuck  in  corners  (8/50) since  seizure  onset. 
However, these signs were only reported in cats that had experienced seizures for more than two 
years. Only nine cats that had experienced seizures for more than two years were reported to be 
normal in-between seizures. Of these 50 cats with a decline in general health, only eight cats had 
been diagnosed with a concurrent disease. Eighty-four percent (42/50) of owners felt that these non-
seizure signs affected their cat’s quality of life. 
 
Discussion 
Feline  audiogenic  reflex  seizures  are  characterized  by  GTCS,  myoclonic  seizures  and  absence 
seizures.  In  gathering  this  data  the  consistency  of  agreement  between  owners’  responses  has 
identified  a  degenerative  syndrome  of  FARS  in  older  cats.  There  appears  to  be  no  gender  bias 
although  cats  exclusively  suffer  from  FARS  later  in  life  within  their  second  decade.  The  sounds   11 
responsible  are  high-pitch  sounds,  often  relatively  quiet  sounds,  with  increasing  loudness  and 
persistence of a sound only serving to enhance the severity of epileptic seizures. Myoclonic jerks or 
seizures with or without impairment of consciousness appear as one of the cardinal signs of FARS 
frequently occurring prior to a GTCS in this population. One third of the population was diagnosed with 
concurrent  diseases  but  this  most  likely  reflected  the  age  of  the  population  rather  than  a  causal 
relationship. This rationale is made on the basis of the static or improving nature of the epilepsy in the 
cats  with  concurrent  medical  conditions.  However,  50%  of  the  population  were  reported  to  have 
hearing impairment or were deaf. Although seizures remained relatively non-progressive, other signs 
developed  making  the disease  slowly  progressive  although  a  decline  in  health  was  only  reported 
exclusively after suffering this epilepsy syndrome for more than two years.  Therapeutic trials with 
levetiracetam suggest this may be more suitable than phenobarbital to control myoclonic seizures and 
GTCS associated with this condition.  Although seizures remained relatively non-progressive, other 
signs developed that were slowly progressive exclusively in cats suffering this epilepsy syndrome for 
more than two years. However, it cannot be determined whether this decline was due to concurrent 
disease and entirely coincidental to the association of FARS, or part of the same syndrome. 
 
We found a high number of Birman cats in the study cohort (31% of cats), strongly suggesting a breed 
predisposition to the condition and thus a hereditary tendency. This is further supported by the fact 
that only Birmans of the seal and blue point lines were affected. The ancestry of the Birman is such 
that the seal and blue points are the original breed colors and cross-mating with other breeds such as 
Persians and Siamese cats have led to the development of other colors that appear unaffected by this 
syndrome. To date, all known Birmans with this condition are of the seal and blue point variety. A 
recessive  or  dominant  mode  of  inheritance  seems  unlikely  based  on  the  limited  pedigree  data 
obtained. It is also important to state that Birmans had the same clinical features of FARS as cats of 
other breeds so although the Birman may represent a different genotype or aetiology, the phenotype 
was comparable. 
 
Animal  models  that  recapitulate  human  epilepsies  are  a  useful  and  convenient  tool  for  studying 
epilepsy. Audiogenic epilepsy in rodents has become one such influential model with sound-induced 
seizures initiated and driven by a brainstem network independent of the forebrain; so-called ‘brainstem 
seizures’
3. The caudal colliculus is critical for the initiation of audiogenic seizures
4. Seizure discharges 
then spread to other brainstem nuclei such as the rostral colliculus, pontine reticular formation, and 
periaqueductal gray
5. Repetitive acoustic stimulation transforms these midbrain electrical stimulations 
into  limbic  ones.  The  spread  of these  seizure discharges  to these forebrain  structures  after  such 
repetitive stimulation results in the clinical manifestation of an epileptic seizure. In the context of the 
cats reported in this study the term audiogenic kindling refers to myoclonic seizures and/or GTCS,   12 
which  develop  after  numerous  daily  sound  exposures.  This  process  of  epileptic  activation  of  the 
forebrain  by  repeated  sound-induced  brainstem  seizures  has  been  referred  to  as  audiogenic 
kindling
6,7. 
 
Levetiracetam has been shown to reduce the frequency and progression of audiogenic seizures
8,9. 
The anti-epileptic effect of levetiracetam against audiogenic seizures has been found to correlate with 
the affinity for the synaptic vesicle glycoprotein 2A
10. Mapping of levetiracetam-selective binding sites 
in  the  rat  brain  identified  high  concentrations  in  structures  such  as  the  rostral  colliculus  and 
periaqueductal gray, i.e. the structures involved in propagation of brainstem seizures
11. In contrast to 
other  anti-epileptic  drugs,  levetiracetam  appears  to  exert  a  more  profound  anti-epileptic  effect  in 
kindled audiogenic seizures compared to non-kindled epileptic animals supporting the hypothesis put 
forward  by  Klitgaard  and  colleagues
8  proposing  that  levetiracetam  has  increased  efficacy  in  the 
kindled epileptic brain.  
 
The results of our study suggest that levetiracetam may aid in reducing the frequency of audiogenic 
seizures in cats as well as their progression (preventing audiogenic kindling) providing an exciting 
opportunity  to  trial  levetiracetam  therapy  for  FARS.  However,  the  small  number  of  cats  receiving 
treatment and the potential for variability in administration means this aspect would require further 
investigation before any claims are made about levetiracetam being a suitable choice for epileptic 
myoclonus and FARS. It is interesting to note that human studies also show that myoclonic seizures 
are highly responsive to treatment with levetiracetam
12-14. 
 
The reason for cats being so sensitive to these seemingly benign high-pitch sounds may have an 
origin in the ultrasonic hearing range of the species. Mice and rats communicate in the ultrasonic 
frequency range (around 40 kHz)
15. It is believed that cats developed a secondary ultrasonic sensitive 
hearing range at these frequencies, presumably as an evolutionary advantage in catching rats and 
mice; their natural prey
15. Common domestic noises with a high component of ultrasonic frequencies - 
such as tearing paper, opening cans, jangling keys and hitting solid surfaces - may sound innocuous 
to us but actually sound more startling to cats that are sensitive to these frequencies. Deafness or 
hearing impairment was reported in half the cats in this study and those in which cross-sectional 
imaging of the head was performed found no apparent cause. It is therefore speculated from our data 
that sensorineural deafness may be associated with audiogenic seizures in cats although these signs, 
especially  given  the  age  of  the  population,  may  have  had  no  relationship  at  all  to  the  FARS. 
Audiogenic  seizures  in  cats  that  are  deaf  seem  paradoxical.  It  is  speculated  that  cats  become 
susceptible to cochlear damage as a consequence of age and exposure to loud noises. The frequency 
of the noise determines the position on the cochlea that the irreversible damage to the outer hair cells   13 
occurs
16. Work by Miller and others showed that the main area of damage was in the middle and lower 
portions of the second turn of the cochlea (corresponding to 7600Hz - everyday ‘loud’ noises to us), 
but that the area of the cochlea associated with detecting higher frequency sounds was not affected
16. 
Therefore these cats will appear deaf to us, although complete hearing loss is not present. Further 
investigations will be required in this area before final conclusions are drawn as hearing impairment 
was  perceived  and  reported  by  owners  and  was  not  confirmed  clinically  making  it  impossible  to 
confirm this clinical feature or its pathogenesis. 
 
An interesting feature of audiogenic seizures in rodents is that one particular strain displays concurrent 
sensorineural deafness.  Mutations in  GIPC3  have been found to cause progressive sensorineural 
hearing loss and audiogenic seizures (juvenile audiogenic monogenic seizure 1, JAMS1) in mice and 
autosomal recessive deafness in humans
17. Another important set of proteins in epilepsy are those 
characterized by the presence of tandem epilepsy associated repeats (EAR), or epitempin (EPTP) as 
it is also known
18. This family consists of several proteins
18; including the four members of the LGI 
(leucine-rich glioma  inactivated  protein;  LGI-1,  LG1-2,  LG1-3,  LG1-4) subfamily  and  VLGR1  (very 
large G protein-coupled receptor 1)
19. Regarding LGI, a protein-truncating mutation in LGI2 in the 
Lagotto romagnolo dog results in benign familial juvenile epilepsy
20. Mutations in VLGR1 have been 
found to be responsible for a monogenic form of auditory seizures in certain strains of mice
21-23 and 
are associated with hearing impairment in these same mice
24. This makes them suitable candidate 
genes  for  genetic  analysis  in  FARS  cases.  FARS  also  shares  similarities  with  the  progressive 
myoclonic  epilepsies  (PMEs).  Progressive  myoclonic  epilepsies  (PMEs)  are  widely  reported  in 
humans  and  are  characterized  by  myoclonic  seizures,  tonic-clonic  seizures,  and  progressive 
neurological deterioration, typically with cerebellar signs and dementia
24. In different disease entities 
various  types  of  seizures  and  neurological  signs  predominate.  Myoclonus  in  PME  is  typically 
fragmentary and multifocal, and is often triggered by an environmental or internal stimulus
25. The age 
of onset, presenting signs, predominance of signs such as seizures, or myoclonus over cerebellar 
signs and dementia vary substantially across the different disorders. There are five main causes of 
PME  in  people  that  have  been  more  accurately  defined  with  recent  advances  in  genetic  studies; 
Lafora  disease,  neuronal  ceroid  lipofuscinosis  (NCLs),  myoclonic  epilepsy  with  ragged  red  fibers 
(MERRF), Unverricht-Lundborg disease (UCL) and Sialidoses
25. Only Lafora disease, NCLs and UCL 
have been associated with reflex seizures. However, few are reported in veterinary medicine with only 
Lafora disease
26 and several different subtypes of the NCLs
27-34 having been shown to have a clear 
genetic cause.  
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Lafora disease has been reported in dogs
26,35-45 and has some clinical correlation with FARS in that 
reflex myoclonic seizures are a feature. The disease has a late onset (median 7 years old) with a 
slowly progressive course
26,35-37; similar to the cats of our report. The myoclonic seizures may  occur in 
response  to  auditory
35,36,46,47  and/or  visual
35-37,46-48  stimuli.  Lafora  disease  in  Miniature  Wirehaired 
Dachshunds has been shown to be caused by the recessive inheritance of a biallelic expansion of a 
dodecamer repeat in the malin gene (EPM2B or NHLRC1)
26. Mutations for the human disease have 
also been identified in the laforin (EPM2A)
49 and the malin (EPM2B or NHLRC1) genes
50,51 making 
these candidates for FARS. 
 
The NCLs are a group of inherited PMEs resulting from lysosomal storage disorders. They typically 
cause  myoclonic  seizures,  often  in  the  terminal  phase,  alongside  other  degenerative  neurological 
signs.  Eight genes  have now been described in canine NCLs;  PPT1
27, TPP1  or  CLN2
28, CLN5
29, 
CLN6
30, CLN8
31, CTSD
32, ATP13A2
33 and ARSG
34. In general, the descriptions of cats with NCLs 
report progressive visual dysfunction and profound neurological decline in cats exclusively less than 
two years old
52-56. Myoclonic seizures are only reported in end-stage disease. No gene defects have 
as yet been identified in feline NCLs
55,56. 
 
The nature of this study meant that set criteria were necessary for the phenotype and for inclusion of 
cats in the study – this may be helpful for performing a genetic study, which will form the second part 
of our investigations. Initial recognition of this disorder  requires a select collection of cases using 
defined  criteria.  However,  it  is  important  to  note  that  other  seizure  types  such  as  absence  and 
myoclonic seizures are likely to occur as the sole seizure type in this syndrome. As an example, it is 
interesting  to  note  that  12  of  the  16  excluded  cats  had  myoclonic  jerks  alone  with  no  GTCS. 
Conversely, it is possible that some cats presented here may have suffered absence seizures that the 
owners had not previously recognized. Furthermore it is known that the frequency and intensity of 
myoclonic jerks varies. For instance, in people they may be perceived only internally, as an electric 
shock-like sensation. For this reason it is possible that owners underestimated the number of episodes 
that their cat was suffering. Therefore the reliance upon clinical historical evidence is likely to overstate 
the prevalence of GTCS when compared to absences and myoclonic seizures. The spectrum of this 
syndrome can be further defined should a genetic marker become apparent for this condition. 
 
It is accepted that this paper has a number of limitations. Not least the fact that we were relying on 
owner accounts, albeit with clinical correlation to the medical history provided by primary veterinarians 
and  video  footage  (in  24%  cats).  For  example,  clinical  confirmation  of  hearing  impairment  would 
require brainstem auditory evoked response or some other form of auditory testing which was not 
performed here. Furthermore, histopathological examination has not been performed making it difficult   15 
to know if one disease process is more likely than another. However, the consistent observations of 
this syndrome, combined with the large number of cats and stringent inclusion criteria suggest that this 
has not adversely affected our results. It is accepted that the inclusion of cats with absence seizures is 
debatable as this seizure type has never been reported in this species. However, these individuals 
had the features that allowed inclusion in our cohort as audiogenic seizures and given the consistent 
descriptions by their owners of absence seizures it is worthy of mention in this report. However, EEG 
would be required to confirm or refute this finding and to further characterize the myoclonic jerks and 
GTCS. 
 
Conclusion 
This study has defined a previously unreported syndrome by using a carefully screened questionnaire 
and medical records. In doing this it has allowed a large cohort to be examined with the purposes of 
genotyping this syndrome. The geriatric nature of this condition is such that it may be overlooked in 
older  cats  that  may  potentially  suffer  from  other  concurrent  conditions  and  so  this  study  serves 
purpose in informing veterinary practitioners of this syndrome. The phenotype is likely to be broader 
than that described but specific criteria were applied to ensure a homogeneous population. Work is 
on-going to identify the genetic basis of this disorder. 
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Figures 
 
Figure 1: A Venn diagram demonstrating the seizure types associated with FARS and their frequency 
in this population. 
 
Supplementary Files 
 
Supplementary Text File: A copy of the questionnaire given to owners of cats with suspected feline 
audiogenic reflex seizures. 
 
Supplementary Video File: Three short clips: (1) a cat exhibiting characteristic myoclonic jerks in 
response  to  a  noise  stimulus;  (2)  a  different  cat  suffering  myoclonic  seizures  triggered  by  sound 
progressing into a generalized tonic-clonic seizure; (3) an audiogenic generalized tonic-clonic seizure 
in an elderly Birman cat. 